Oscillating Positive Expiratory Pressure Devices Market Global Report 2028
Si prevede che il mercato dei dispositivi a pressione espiratoria positiva oscillante (OPEP) crescerà da 125,66 milioni di dollari nel 2021 a 179,34 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 5,2% nel periodo 2021-2028.
I dispositivi a pressione espiratoria positiva oscillatoria (OPEP) sono stati utilizzati come supplemento alla tradizionale fisioterapia toracica (CPT) per aiutare l'eliminazione delle secrezioni respiratorie nelle persone che non possono tossire, specialmente quelle con condizioni croniche. L’uso dei dispositivi OPEP è ancora limitato nelle patologie croniche delle vie aeree come la fibrosi cistica, le bronchiectasie, la bronchite, l’asma bronchiale e la sindrome da discinesia ciliare primaria. Nella broncopneumopatia cronica ostruttiva (BPCO), i dispositivi a pressione espiratoria positiva oscillante (OPEP) aiutano a eliminare l'espettorato.
La crescita del mercato dei dispositivi a pressione espiratoria positiva oscillante (OPEP) è attribuita alla crescente prevalenza della broncopneumopatia cronica ostruttiva (BPCO) e dell’asma, nonché ai progressi nelle tecnologie mediche. Tuttavia, la scarsa consapevolezza e l’accesso limitato ai dispositivi OPEP ostacolano la crescita del mercato.
Personalizza la ricerca in base alle tue esigenze
Possiamo ottimizzare e personalizzare l'analisi e l'ambito che non sono soddisfatti dalle nostre offerte standard. Questa flessibilità ti aiuterà a ottenere le informazioni esatte necessarie per la pianificazione aziendale e il processo decisionale.
Mercato dei dispositivi a pressione espiratoria positiva oscillante (OPEP): approfondimenti strategici
CAGR (2021 - 2028)5,2%- Dimensione del mercato nel 2021:
125,66 milioni di dollari - Dimensione del mercato nel 2028:
179,34 milioni di dollari
Dinamiche di mercato
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Giocatori chiave
- Allergan Plc.
- PARI GmbH
- Smiths Medical
- AirPhysio
- D?R BURTON ASSISTENZA SANITARIA
- Medica Holdings, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- Sanità capace
- Trudell Medical Internazionale
Panoramica regionale
- Nord America
- Europa
- Asia-Pacifico
- America meridionale e centrale
- Medio Oriente e Africa
Segmentazione del mercato
- Dispositivi PEP per boccaglio
- Dispositivi PEP con maschera facciale
- Dispositivi PEP per bottiglie
- Broncopneumopatia cronica ostruttiva
- Farmacie ospedaliere
- Farmacie on-line
- Farmacie al dettaglio
- Il PDF di esempio mostra la struttura del contenuto e la natura delle informazioni con analisi qualitative e quantitative.
Approfondimenti di mercato
La crescente prevalenza della broncopneumopatia cronica ostruttiva (BPCO) e dell’asma stimola la crescita del mercato
L’incidenza della BPCO e della fibrosi cistica è in aumento in tutto il mondo. Secondo l’Organizzazione Mondiale della Sanità (OMS), le riacutizzazioni della BPCO sono eventi critici. La disabilità e la mortalità legate alla BPCO spingono la domanda di dispositivi OPEP. Secondo il Centro per il controllo e la prevenzione delle malattie (CDC), nel 2018 è stata diagnosticata la bronchite cronica a circa 9 milioni di adulti . Inoltre, l’asma sta diventando comune tra persone di tutte le età, sesso e razza. Secondo il CDC, circa 300 milioni di persone in tutto il mondo soffrono di asma, con la prevista aggiunta di 100 milioni entro il 2025. La prevalenza, la gravità e la mortalità dell'asma variano notevolmente negli Stati Uniti. L’asma colpisce più di 25 milioni di persone negli Stati Uniti, ovvero il 7,7% degli adulti e l’8,4% dei bambini. Secondo il Global Asthma Report 2018 di Auckland, in Nuova Zelanda, l’asma si colloca al 16° posto tra le principali cause di disabilità e al 28° tra le maggiori fonti di carico di malattia, secondo la valutazione degli anni di vita aggiustati per la disabilità. È comune nei paesi ad alto reddito, mentre la maggior parte dei decessi correlati all’asma si verifica nei paesi a basso e medio reddito. Pertanto, la crescente prevalenza di BPCO e asma spinge la domanda di dispositivi per la pulizia delle mucose, come i dispositivi OPEP, che sostiene la crescita del mercato dei dispositivi a pressione espiratoria positiva oscillante (OPEP).
Approfondimenti basati sul prodotto
Il mercato dei dispositivi a pressione espiratoria positiva oscillante (OPEP), in base al prodotto, è segmentato in dispositivi PEP con boccaglio, dispositivi PEP con maschera facciale e dispositivi PEP con bottiglia. Il segmento dei dispositivi PEP con boccaglio ha detenuto la quota maggiore del mercato nel 2021. Inoltre, si prevede che registrerà un CAGR del 5,3% nel mercato durante il periodo di previsione. Il boccaglio PEP aiuta a rimuovere il muco dai polmoni. Può anche prevenire il collasso polmonare o riaprire aree che sono collassate. Uno dei fattori chiave che guidano il mercato dei dispositivi PEP con boccaglio è la crescente popolazione anziana, unita a tassi più elevati di malattie croniche come la broncopneumopatia cronica ostruttiva (BPCO) e l’asma. Secondo i Centri per il controllo e la prevenzione delle malattie (CDC), entro il 2020 a circa 9 milioni di persone verrà diagnosticata la bronchite cronica, determinando così la necessità di dispositivi con boccaglio.
Approfondimenti sulle indicazioni
Sulla base delle indicazioni, il mercato dei dispositivi a pressione espiratoria positiva oscillante (OPEP) è segmentato in broncopneumopatia cronica ostruttiva (BPCO), asma, bronchite, bronchiectasie, fibrosi cistica e altri. Il segmento BPCO deteneva la quota maggiore del mercato nel 2021. Tuttavia, si prevede che il segmento dell’asma registrerà un CAGR del 6,0% durante il periodo di previsione. La BPCO è una malattia comune e curabile caratterizzata da progressiva limitazione del flusso aereo e distruzione dei tessuti. È associata a cambiamenti strutturali polmonari dovuti a infiammazione cronica derivante dall'esposizione prolungata a particelle o gas nocivi, più comunemente fumo di sigaretta. L’infiammazione cronica provoca il restringimento delle vie aeree e una diminuzione della retrazione polmonare.
Il lancio e l’approvazione dei prodotti sono strategie comunemente adottate dalle aziende per espandere la propria presenza globale e i portafogli di prodotti. Inoltre, gli operatori del mercato dei dispositivi a pressione espiratoria positiva oscillante (OPEP) si concentrano sulla strategia di partnership per ampliare la propria clientela, che, a sua volta, consente loro di mantenere il proprio marchio a livello globale. Si prevede che il mercato fiorirà nei prossimi anni grazie allo sviluppo di prodotti innovativi da parte degli operatori del mercato.
Ambito del rapporto sul mercato dei dispositivi oscillanti a pressione espiratoria positiva
Attributo del rapporto | Dettagli |
---|---|
Dimensioni del mercato nel 2021 | 125,66 milioni di dollari |
Dimensioni del mercato entro il 2028 | 179,34 milioni di dollari |
CAGR globale (2021-2028) | 5,2% |
Dati storici | 2019-2020 |
Periodo di previsione | 2022-2028 |
Segmenti coperti | Per prodotto
|
Regioni e paesi coperti | Nord America
|
Leader di mercato e profili aziendali chiave |
|
- Il PDF di esempio mostra la struttura del contenuto e la natura delle informazioni con analisi qualitative e quantitative.
Profili aziendali
- Allergan Plc.
- PARI GmbH
- La medicina di Smith
- AirPhysio
- D•R BURTON ASSISTENZA SANITARIA
- Medica Holdings, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- Sanità capace
- Trudell Medical Internazionale
- Mercurio medico
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
COVID-19 was more likely to hospitalize those with moderate-to-severe or uncontrolled asthma. The coronavirus can cause pneumonia, blood clots, and acute respiratory distress syndrome, among other lung issues. The epidemic has added new levels of anxiety for both patients and clinicians for the nearly 37 million Americans who live with a chronic lung illness like asthma or chronic obstructive pulmonary disease. Caring for people with COVID-19 and underlying COPD is very difficult at this time. Certain treatments for COPD patients, such as nebulized bronchodilators and non-invasive ventilation (NIV), are thought to enhance the risk of viral transmission via aerosols. Although oscillating positive expiratory pressure (OPEP) devices have been in use with the increasing cases of COVID-19 in the region as studies shows oscillating positive expiratory pressure (OPEP) devices results in minimizing the effect of respiratory distress due to COVID. Also, the Positive Expiratory Pressure (PEP) flute therapy and Positive End-Expiratory Pressure (PEEP) proved to be led to a small yet statistically significant decrease in the severity of respiratory symptoms in adults with COVID-19 recovering at home as per various research studies.
North America held the largest share of the oscillating positive expiratory pressure (OPEP) devices market and is expected to continue its position over the coming years. These oscillating positive expiratory pressure (OPEP) devices are in high demand in North America's regional segment. Furthermore, the presence of a robust medical infrastructure and the early availability of new products and equipment are aiding the area market's overall development.
Trudell Medical International and Allergan Plc are the top two companies that hold huge market shares in the Oscillating Positive Expiratory Pressure (OPEP) Devices market.
The Oscillating Positive Expiratory Pressure (OPEP) Devices market majorly consists of players such as Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; D•R BURTON HEALTHCARE; Medica Holdings, LLC; CEGLA Medizintechnik GmbH & Co. KG; Able Healthcare; Trudell Medical International; Mercury Medical amongst others.
The hospital pharmacies segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 60.48% in 2021.
The mouthpiece PEP devices segment held the largest share of the market in the global oscillating positive expiratory pressure (OPEP) devices market and held the largest market share of 94.68% in 2021.
The chronic obstructive pulmonary disease (COPD) segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 34.60% in 2021.
Oscillatory positive expiratory pressure (OPEP) devices have been used as a supplement to traditional chest physiotherapy (CPT) to aid in the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. In chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome, the usage of OPEP devices is still limited. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices are said to help with sputum clearance.
Key factors that are driving the growth of this market are the growing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and rising technological advancements are expected to boost the market growth for oscillating positive expiratory pressure (OPEP) devices over the years.
The CAGR value of the oscillating positive expiratory pressure (OPEP) devices market during the forecasted period of 2021–2028 is 5.2%.
The List of Companies - Oscillating Positive Expiratory Pressure (OPEP) Devices Market
- Allergan Plc.
- PARI GmbH
- Smiths Medical
- AirPhysio
- D•R BURTON HEALTHCARE
- Medica Holdings, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- Able Healthcare
- Trudell Medical International
- Mercury Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.